文献速递乳腺MR乳腺X线CT

乳腺癌对比增强影像分期:MRI、CEM与专用乳腺CT的利弊

Breast cancer staging with contrast-enhanced imaging. The benefits and drawbacks of MRI, CEM, and dedicated breast CT.
PubMed 文献 · Eur J Radiol · 2025-02-27

本文综述对比增强影像在乳腺癌治疗前分期中的作用,涵盖DCE-MRI、对比增强乳腺X线摄影(CEM)和专用对比增强乳腺CT(dCEBCT),讨论各模态的现状、局限与挑战,并强调关键乳腺癌表现及其影像表型的最优解读。

要点

  • DCE-MRI提供三维病变范围评估和病灶特征描述,兼顾形态学与功能信息。
  • CEM和dCEBCT基于对比增强X线技术,具有高空间分辨率。
  • 综述强调在影像学(解剖与预后)分期时代优化解读各对比增强模态的影像表型。

核心结论

  • 对比增强影像技术可突出新生血管增多区域,在乳腺癌分期中似乎不可或缺。
  • DCE-MRI提供全面的三维病变范围评估和病灶特征描述,捕捉形态学和功能学方面,对治疗和监测至关重要。
  • 基于DCE-MRI的成熟方法,CEM和dCEBCT等高空间分辨率对比增强X线技术已经出现。

研究设计与样本

  • 综述,检索范围与纳入文献原文未报告。

关键影像表现/征象

  • 对比增强机制突出新生血管增多区域。
  • DCE-MRI捕捉病灶的形态学和功能学特征。
  • CEM和dCEBCT基于X线技术,具有高空间分辨率。

诊断标准与关键数值

  • 原文未报告诊断标准与关键数值。

临床应用与阅片要点

  • 综述强调关键乳腺癌表现及其影像表型的最优解读,以用于影像学(解剖与预后)分期。
  • 临床影像分期目前依赖数字乳腺X线摄影(DM)、数字乳腺断层合成(DBT)和超声等常规模态。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Pretherapeutic breast cancer staging is pivotal for patient-centered disease management, guiding treatment stratification and assessing prognostic outcomes. Breast imaging plays a key role in both anatomic and prognostic staging by providing comprehensive insights into disease extent, localization, and tumor aggressiveness characteristics. To date, clinical image-based staging relies on conventional modalities such as digital mammography (DM), digital breast tomosynthesis (DBT), and ultrasound. Considering the phenotypic disparities of breast cancer and their relation to treatment response, other imaging techniques based on contrast-enhanced mechanisms, which highlight areas of increased neovascularity, appear indispensable in breast cancer staging. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) offers a comprehensive 3-dimensional assessment of extent of disease and characterization of lesions, capturing both morphological and functional aspects which are crucial for treatment and monitoring of the disease. Based on this established approach, contrast-enhanced x-ray-based techniques, with high spatial resolution, such as contrast-enhanced mammography (CEM) and dedicated contrast-enhanced breast computed tomography (dCEBCT), have emerged. This review outlines the current status, limitations, and ongoing challenges associated with each one contrast-enhanced imaging modality, while emphasis is given to key breast cancer manifestations and the optimal interpretation of their imaging phenotypes, in the current era of image-based (anatomic and prognostic) breast cancer staging.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Tsarouchi M, Hoxhaj A, Portaluri A, et al. Breast cancer staging with contrast-enhanced imaging. The benefits and drawbacks of MRI, CEM, and dedicated breast CT. Eur J Radiol. 2025. PMID: 40036929. doi:10.1016/j.ejrad.2025.112013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。